proteins that ensure its transmembrane movement. Carrier
proteins in mammalian cells are glucose
Nasyrova, Regina F.,
Shnayder, Natalia A.,
Osipova, Sofia M.,
Khasanova, Aiperi K.,
Efremov, Ilya S.,
Al-Zamil, Mustafa,
Petrova, Marina M.,
Narodova, Ekaterina A.,
Garganeeva, Natalia P.,
Shipulin, German A. (2023) of Science E-Library) and online resources: The Human
Protein
Atlas; GeneCards: The Human Gene Database; US
Bogliolo, M.,
Catucci, I.,
Caleca, L.,
Lasheras, S.V.,
Pujol, R.,
Kiiski, J.I.,
Muranen, T.A.,
Barnes, D.R.,
Dennis, J.,
Michailidou, K.,
Bolla, M.K.,
Leslie, G.,
Figlioli, G. (2019) recurrent
protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) Myeloid differential
protein-2 (MD2) has been shown to play a critical role in the progression
Mukhametov, U.F.,
Lyulin, S.V.,
Borzunov, D.Y.,
Gareev, I.F.,
Beylerli, O.A.,
Sufianov, A.A. (2022) , it is believed that signaling of bone morphogenetic
proteins (BMPs) plays a key role in the overall process of HO
Tyurin, A.V.,
Salimgareeva, M.K.,
Miniakhmetov, I.R.,
Khusainova, R.I.,
Samorodov, A.,
Pavlov, V.N.,
Kzhyshkowska, J. (2022) patients was examined for the levels of C-reactive
protein, biomarker of systemic inflammation
ЭПИДЕМИОЛОГИЯ И ВОЗМОЖНЫЕ ФАКТОРЫ РИСКА МИКОБАКТЕРИОЗОВ ЛЕГКИХПетров, И.В.,
Петрова, Ф.С.,
Фазылов, В.Х.,
Соколова, Н.Г.,
Petrov, I.V.,
Petrova, F.S.,
Fazylov, V.H.,
Sokolova, N.G. (2024) использованием программы
StatTech v. 4.3.2. Заключение. Полученные результаты позволили определить, что